Country/Language

Are you ready to explore a potential option for controlling lupus nephritis?

Do I Qualify?

If so, consider joining the HIB-202-101 study, a lupus nephritis clinical trial testing the safety and tolerability of an investigational study medication, known as felzartamab, as a potential treatment for lupus nephritis.

Study Overview
Study Medication
About Lupus Nephritis
About Clinical Research

See if you may qualify

Take the short pre-screening questionnaire to find out if you may qualify for the HIB-202-101 study.

Do I Qualify?

Contact a study clinic near you

Use the interactive map and search bar navigation to locate and contact a nearby study clinic location.

Study Clinic Locations
Study Information
HomeHIB-202-101 StudyStudy MedicationAbout Lupus Nephritis
Join the Study
Do I Qualify?Study Clinic Locations
Resources
About Clinical Research
Privacy PolicyTerms and Conditions
Copyright © 2024 Medpace